The Congenital and Limb-Girdle Muscular Dystrophies: Sharpening the Focus, Blurring the Boundaries

Archives of Neurology

Volumn 61, Issue 2, 2004, Pages 189-199

  Kirschner, Janbernd ^a   Bönnemann, Carsten G ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 3; DYSFERLIN; FUKUTIN RELATED PROTIEN; GENE PRODUCT; LAMIN A; LAMIN C; UNCLASSIFIED DRUG;

CEREBELLUM ATROPHY; CLINICAL FEATURE; CONGENITAL DISORDER; DIAGNOSTIC APPROACH ROUTE; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; GENE MUTATION; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MENTAL DEFICIENCY; MICROCEPHALY; MUSCLE EYE BRAIN DISEASE; MUSCLE HYPERTROPHY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; REVIEW; SYMPTOM; WALKER WARBURG SYNDROME;

ADOLESCENT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DYSTROPHIN; HUMANS; INFANT; MEMBRANE PROTEINS; MUSCULAR DYSTROPHIES; PHENOTYPE;

EID: 1042268038     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.2.189     Document Type: Review

References (114)

1. Meryon E. On granular and fatty degeneration of the voluntary muscles. Med Chir Trans. 1852;35:73-84.
2. Duchenne G. Recherches surla paralysis musculaire pseudohypertropique on paralysie myosclerosique. Arch Gen Med. 1868;11:5-25.
3. Batten F. Three cases of myopathy, infantile type. Brain. 1903;26:147-148.
4. Bell J. On pseudohypertrophic and allied types of progressive muscular dystrophy. In: Fischer RA, ed. The Treasury of Human Inheritance. London, England: Cambridge University Press; 1943:283-342.
5. Bushby KMD. Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC Consortium on Limb-Girdle Dystrophies. Neuromuscul Disord. 1995;5:71-74.
6. Brockington M, Blake DJ, Prandini P, et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am J Hum Genet. 2001;69:1198-1209.
7. Longman C, Beltran-Valero De Bernabe D, Brockington M, Muntoni F, Brunner HG, Van Bokhoven H. FKRP mutation in a patient with Walker-Warburg syndrome [abstract]. Neuromuscul Disord. 2003;13:638.
8. Harel T, Goldberg Y, Shalev SA, Chervinski I, Ofir R, Birk OS. Limb-girdle muscular dystrophy 21: phenotypic variability within a large consanguineous Bedouin family associated with a novel FKRP mutation. Eur J Hum Genet. October 1, 2003 [Epub ahead of print].
9. Brockington M, Yuva Y, Prandini P, et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 21 as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet. 2001;10: 2851-2859.
10. Mercuri E, Brockington M, Straub V, et al. Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol. 2003;53:537-542.
11. Poppe M, Cree L, Bourke J, et al. The phenotype of limb-girdle muscular dystrophy type 21. Neurology. 2003;60:1246-1251.
12. Bashir R, Britton S, Strachan T, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet. 1998;20:37-42.
13. Liu J, Aoki M, Illa I, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle musuclar dystrophy. Nat Genet. 1998;20: 31-36.
14. Bonne G, Di Barletta MR, Varnous S, et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet. 1999;21:285-288.
15. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med. 1999;341:1715-1724.
16. Novelli G, Muchir A, Sangiuolo F, et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet. 2002;71:426-431.
17. De Sandre-Giovannoli A, Chaouch M, Kozlov S, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet. 2002;70:726-736.
18. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423:293-298.
19. De Sandre-Giovannoli A, Bernard R, Cau P, et al. Lamin A truncation in Hutchinson-Gilford progeria. Science. 2003;300:2055.
20. Chen L, Lee L, Kudlow BA, et al. LMNA mutations In atypical Werner's syndrome. Lancet. 2003;362:440-445.
21. Hoffman EP, Brown RJ, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919-928.
22. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev. 2002;82:291-329.
23. Bönnemann CG. Limb-girdle muscular dystrophies. In: Jones HR, DeVivo DC, Darras BT, eds. Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach. Philadelphia, Pa: Butterworth Heinemann; 2003: 717-752.
24. Michele DE, Barresi R, Kanagawa M, et al. Post-translational disruption of dystroglycan ligand interactions in congenital muscular dystrophies. Nature. 2002; 418:417-421.
25. Yoshida A, Kobayashi K, Manya H, et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransterase, POMGnT1. Dev Cell. 2001;1:717-724.
26. Kobayashi K, Nakahori Y, Miyake M, et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature. 1998;394:388-392.
27. Beltran-Valero De Bernabe D, Currier S, Steinbrecher A, et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet. 2002;71:1033-1043.
28. Longman C, Brockington M, Torelli S, et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet. 2003;12:2853-2861.
29. Brockington M, Sewry CA, Herrmann R, et al. Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42. Am J Hum Genet. 2000;66:428-435.
30. Hayashi YK, Chou FL, Engvall E, et al. Mutations in the integrin alpha7 gene cause congenital myopathy. Nat Genet. 1998;19:94-97.
31. Villanova M, Mercuri E, Bertini E, et al. Congenital muscular dystrophy associated with calf hypertrophy, microcephaly and severe mental retardation in three Italian families: evidence for a novel CMD syndrome. Neuromuscul Disord. 2000; 10:541-547.
32. Voit T, Parano E, Straub V, et al. Congenital muscular dystrophy with adducted thumbs, ptosis, external ophthalmoplegia, mental retardation and cerebellar hypoplasia: a novel form of CMD. Neuromuscul Disord. 2002;12:623-630.
33. Ruggieri V, Lubieniecki F, Meli F, et al. Merosin-positive congenital muscular dystrophy with mental retardation, microcephaly and central nervous system abnormalities unlinked to the Fukuyama muscular dystrophy and muscular-eye-brain loci: report of three siblings. Neuromuscul Disord. 2001;11:570-578.
34. Echenne B, Rivier F, Tardieu M, et al. Congenital muscular dystrophy and cerebellar atrophy. Neurology. 1998;50:1477-1480.
35. Michele DE, Campbell KP. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem. 2003;278: 15457-15460.
36. Bönnemann CG. Disorders of the sarcoglycan complex (sarcoglycanopathies). In: Deymeer F, ed. Neuromuscular Diseases: From Basic Mechanisms to Clinical Management. Basel, Switzerland: S Karger AG; 2000:26-43. Monographs in Clinical Neuroscience; vol 18.
37. Roberds SL, Leturcq F, Allamand V, et al. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell. 1994;78:625-633.
38. Bönnemann CG, Modi R, Noguchi S, et al. β-Sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet. 1995;11:266-273.
39. Lim LE, Duclos F, Broux O, et al. β-Sarcoglycan (43 DAG): characterization and involvement in a recessive form of limb-girdle muscular dystrophy linked to chromosome 4q12. Nat Genet. 1995;11:257-265.
40. Noguchi S, McNally EM, Ben Othmane K, et al. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science. 1995;270:819-822.
41. Nigro V, de Sa Moriera E, Piluso G, et al. The 5q autosomal recessive limb-girdle muscular dystrophy (LGMD 2F) is caused by a mutation in the δ-sarcoglycan gene. Nat Genet. 1996;14:195-198.
42. Zimprich A, Grabowski M, Asmus F, et al. Mutations in the gene encoding E-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet. 2001;29:66-69.
43. Crosbie RH, Lebakken CS, Holt KH, et al. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol. 1999; 145:153-165.
44. Albrecht DE, Froehner SC. Syntrophins and dystrobrevins: defining the dystrophin scaffold at synapses. Neurosignals. 2002;11:123-129.
45. Grady RM, Grange RW, Lau KS, et al. Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol. 1999;1:215-220.
46. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem. 1998;273:5419-5422.
47. Yarbrough TL, Lu T, Lee HC, Shibata EF. Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude. Circ Res. 2002;90:443-449.
48. Selcen D, Stilling G, Engel AG. The earliest pathologic alterations in dysferlinopathy. Neurology. 2001;56:1472-1481.
49. Betz RC, Schoser BG, Kasper D, et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet. 2001; 28:218-219.
50. Davis DB, Doherty KR, Delmonte AJ, McNally EM. Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J Biol Chem. 2002;277:22883-22888.
51. Bansal D, Miyake K, Vogel SS, et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature. 2003;423:168-172.
52. Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet. 1995;11:216-218.
53. Jones KJ, Morgan G, Johnston H, et al. The expanding phenotype of laminin α2 chain (merosin) abnormalities: case series and review. J Med Genet. 2001; 38:649-657.
54. Pegoraro E, Marks H, Garcia CA, et al. Laminin α2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology. 1998;51:101-110.
55. Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromuscul Disord. 1995;5:301-305.
56. Tillet E, Wiedemann H, Golbik R, et al. Recombinant expression and structural and binding properties of alpha 1(VI) and alpha 2(VI) chains of human collagen type VI. Eur J Biochem. 1994;221:177-185.
57. Kuo HJ, Maslen CL, Keene DR, Glanville RW. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem. 1997;272:26522-26529.
58. Jöbsis GJ, Keizers H, Vreijling JP, et al. Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. Nat Genet. 1996; 14:113-115.
59. Camacho Vanegas O, Bertini E, Zhang RZ, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci U S A. 2001;98:7516-7521.
60. Higuchi I, Shiraishi T, Hashiguchi T, et al. Frameshift mutation in the collagen VI gene causes Ullrich's disease. Ann Neurol. 2001;50:261-265.
61. Demir E, Sabatelli P, Allamand V, et al. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. Am J Hum Genet. 2002;70:1446-1458.
62. Pan TC, Zhang RZ, Sudano DG, Marie SK, Bönnemann CG, Chu ML. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Am J Hum Genet. 2003;73:355-369.
63. Sanoudou D, Beggs AH. Clinical and genetic heterogeneity in nemaline myopathy-a disease of skeletal muscle thin filaments. Trends Mol Med 2001;7:362-368.
64. Moreira ES, Wiltshire TJ, Faulkner G, et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the samomeric protein telethonin. Nat Genet. 2000;24:163-166.
65. Hauser MA, Horrigan SK, Salmikangas P, et al. Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet. 2000;9:2141-2147.
66. Hackman P, Vihola A, Haravuori H, et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet. 2002;71:492-500.
67. Muchir A, Bonne G, van der Kooi AJ, et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet. 2000;9:1453-1459.
68. Hutchison CJ. Lamins: building blocks or regulators of gene expression? Nat Rev Mol Cell Biol. 2002;3:848-858.
69. Richard I, Broux O, Allamand V, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 1995;81:27-40.
70. Richard I, Roudaut C, Saenz A, et al. Calpainopathy: a survey of mutations and polymorphisms. Am J Hum Genet. 1999;64:1524-1540.
71. Frosk P, Weiler T, Nylen E, et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet. 2002;70:663-672.
72. Moghadaszadeh B, Petit N, Jaillard C, et al. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet. 2001;29:17-18.
73. Ferreiro A, Quijano-Roy S, Pichereau C, et al. Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet. 2002;71:739-749.
74. Dubowitz V. The Congenital Myopathies: Muscle Disorders in Childhood. London, England: WB Saunders; 1995:134-176.
75. Mostacciuolo ML, Miorin M, Martinello F, Angelini C, Perini P, Trevisan CP. Genetic epidemiology of congenital muscular dystrophy in a sample from northeast Italy. Hum Genet. 1996;97:277-279.
76. Shorer Z, Philpot J, Muntoni F, Sewry C, Dubowitz V. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy. J Child Neurol. 1995;10:472-475.
77. Tan E, Topaloglu H, Sewry C, et al. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency. Neuromuscul Disord. 1997;7:85-89.
78. Topaloglu H, Brockington M, Yuva Y, et al. FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts. Neurology. 2003;60:988-992.
79. Ullrich O. Kongenitale atonisch-sklerotische Muskeldystrophie, ein weiterer Typus der heredodegenerativen Erkrankungen des neuromuskularen Systems. Z Ges Neurol Psychiatr. 1930;126:171-201.
80. Mercuri E, Yuva Y, Brown SC et al. Collagen VI involvement in Ullrich syndrome a clinical, genetic, and immunohistochemical study. Neurology. 2002; 58:1354-1359.
81. Moghadaszadeh B, Desguerre I, Topaloglu H, et al. Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35-38. Am J Hum Genet. 1998;62:1439-1445.
82. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type: clinical genetic and pathological considerations. Brain Dev. 1981;3:1-29.
83. Santavuori P, Leisti J, Kruus S. Muscle, eye and brain disease: a new syndrome. Neuropãdiatrie. 1977;8:553-558.
84. Santavuori P, Somer H, Sainio K, et al. Muscle-eye-brain disease (MEB). Brain Dev. 1989;11:147-153.
85. Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet. 1989;32:195-210.
86. Silan F, Yoshioka M, Kobayashi K, et al. A new mutation of the fukutin gene in a non-Japanese patient. Ann Neurol. 2003;53:392-396.
87. Taniguchi K, Kobayashi K, Saito K, et al. Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. Hum Mol Genet. 2003;12:527-534.
88. Bushby KM, Beckmann JS. The limb girdle muscular dystrophies-proposal for a new nomenclature. Neuromuscul Disord. 1995;5:337-343.
89. van der Koo AJ, Barth PG, Busch HFM, et al. The clinical spectrum of limb girdle muscular dystrophy: a survey in the Netherlands. Brain. 1996;119:1471-1480.
90. van der Kooi AJ, de Visser M, Barth PG. Limb girdle muscular dystrophy: reappraisal of a rejected entity. Clin Neurol Neurosurg. 1994;96:209-218.
91. Mora M, Moroni I, Uziel G, et al. Mild clinical phenotype in a 12-year-old boy with partial merosin deficiency and central and peripheral nervous system abnormalities. Neuromuscul Disord. 1996;6:377-381.
92. Naom I, D'Alessandro M, Sewry CA, et al. Laminin α2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy. Neuromuscol Disord. 1998;8:495-501.
93. Muntoni F, Lichtarowicz-Krynska EJ, Sewry CA, et al. Early presentation of X-linked Emery-Dreifuss muscular dystrophy resembling limb-girdle muscular dystrophy. Neuromuscul Disord. 1998;8:72-76.
94. Scacheri PC, Gillanders EM, Subramony SH, et al. Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype. Neurology. 2002;58: 593-602.
95. Passos-Bueno MR, Vainzof M, Moreira ES, Zatz M. Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G. Am J Med Genet. 1999;82:392-398.
96. Ginjaar HB, van der Kooi AJ, Ceelie H, et al. Sarcoglycanopathies in Dutch patients with autosomal recessive limb girdle muscular dystrophy. J Neurol. 2000; 247:524-529.
97. Fanin M, Duggan DJ, Mostacciuolo ML, et al. Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. J Med Genet. 1997; 34:973-977.
98. Melacini P, Fanin M, Duggan DJ, et al. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve. 1999;22:473-479.
99. Fardeau M, Hillaire D, Mignard C, et al. Juvenile limb-girdle muscular dystrophy: clinical, histopathological and genetic data from a small community living in the Reunion Islands. Brain. 1996;119:295-308.
100. Linssen WH, Notermans NC, Van der Graaf Y, et al. Miyoshi-type distal muscular dystrophy: clinical spectrum in 24 Dutch patients. Brain. 1997;120:1989-1996.
101. Argov Z, Sadeh M, Mazor K, et al. Muscular dystrophy due to dysferlin deficiency in Libyan Jews: clinical and genetic features. Brain. 2000;123:1229-1237.
102. Weiler T, Bashir R, Anderson LV, et al. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet. 1999;8:871-877.
103. Moreira ES, Vainzof M, Marie SK, Sertie AL, Zatz M, Passos-Bueno MR. The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am J Hum Genet. 1997;61:151-159.
104. Weiler T, Greenberg CR, Zelinski T, et al. A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another limb-girdle muscular dystrophy locus. Am J Hum Genet. 1998;63:140-147.
105. Udd B. Limb-girdle type muscular dystrophy in a large family with distal myopathy: homozygous manifestation of a dominant gene? J Med Genet. 1992; 29:383-389.
106. Messina DN, Speer MC, Pericak-Vance MA, McNally EM. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet. 1997;61:909-917.
107. Speer MC, Vance JM, Grubber JM, et al. Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7. Am J Hum Genet. 1999;64:556-562.
108. Palenzuela L, Andreu AL, Gamez J, et al. A novel autosomal dominant limb-girdle muscular dystrophy (LGMD 1F) maps to 7q32.1-32.2. Neurology. 2003; 61:404-406.
109. van der Kooi AJ, Ledderhof TM, de Voogt WG, et al. A newly recognized autosomal dominant limb girdle muscular dystrophy with cardiac involvement. Ann Neurol. 1996;39:636-642.
110. Carbone I, Bruno C, Sotgia F, et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology. 2000;54:1373-1376.
111. Herrmann R, Straub V, Blank M, et al. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum Mol Genet. 2000;9:2335-2340.
112. Tateyama M, Aoki M, Nishino I, et al. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology. 2002;58:323-325.
113. Bönnemann CG, Darras BT, Lidov HGW, Feener CA, Shapiro FD, Kunkel LM. Strength improvement on prednisone in a patient with limb-girdle muscular dystrophy 2C (primary γ-sarcoglycanopathy) [abstract]. Ann Neurol. 1997;42:531-532.
114. Walter MC, Lochmuller H, Reilich P, et al. Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study. Neurology. 2000; 54:1848-1850.